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Summary
Background: Hospital admissions for exacerbations of chronic obstructive pulmonary disease
(COPD) impact considerably on disease evolution and healthcare provision. Building on
previous studies, this study postulated that COPD patients could be stratified by risk of admis-
sion to determine which groups provide the greatest burden on resources, and how interven-
tions should be targeted to prevent admissions.
Methods: COPD admissions during 1997e2003 in three Strategic Health Authorities in England
were analysed (nZ 80,291). Patients admitted during winter (1 Novembere31 March) were
stratified into three groups according to the number of admissions during the previous year:
0 (NIL), 1e2 (MOD) or 3 (FRQ). Winter weeks were classified as ‘‘average’’, ‘‘above average’’,
‘‘high’’, or ‘‘very high’’ risk, compared with the long-term mean.
Results: The risk of admission during winter for FRQ and MOD patients was 40% and 12% respec-
tively. NIL patients contributed to 70% of winter admissions, and 90% of the variation between
‘‘average’’ and ‘‘very high’’ weeks, versus 9% and 1% for MOD and FRQ.
Conclusions: Patients with no previous admissions have lower individual risk, but contribute to
a high overall utilisation of health care resources and should be targeted to prevent admis-
sions. Focusing upon high-risk patients (frequent attenders or more severe) may only reduce
a small proportion of admissions, and therefore clinicians should ensure that all COPD patients
receive appropriate therapy to reduce risk of exacerbations.
Crown Copyright ª 2008 Published by Elsevier Ltd. All rights reserved.
Introduction
Chronic obstructive pulmonary disease (COPD) is one of the
most frequent causes of hospital admission and a major
burden to health services around the world. World Health
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Organization (see http://www.who.int/en/) predictions
suggest that it is set to become the fourth leading cause by
2030, accounting for 7.9% of total deaths.1e4 COPD is esti-
mated to affect three million people in England, accounting
for over 30,000 deaths, 1.4 million general practice
consultations and one million inpatient bed days each
year.5 COPD admissions to hospital in England have been
rising on average at nearly 3% per annum (pa) since 1997/
98,6 and the public health burden is expected to continue
to rise as the population ages and cigarette smoking
persists.5 The cost to the National Health Service (NHS) in
England has been estimated to be over £800 million, with
indirect costs to the economy a further £2.7 billion.5
Current Department of Health policy in England, United
Kingdom (UK), aims to ‘‘improve health outcomes for
people with long-term conditions by offering a personal-
ised care plan for vulnerable people most at risk; and to
reduce emergency bed days by 5% by 2008 [from 2003/04
levels], through improved care in primary care and
community settings for people with long-term condi-
tions.’’.7 The UK Met Office has been working with primary
care organisations in the NHS to develop a health fore-
casting service that triggers the provision of anticipatory
care to patients with COPD. The overall aim is to reduce
the risk of hospital admission, through targeted interven-
tions and improved management of exacerbations. The
Met Office/NHS service was piloted in winters 2004/05 and
2005/06 in general practices in more than 40 Primary Care
Trusts (PCTs) in ten Strategic Health Authorities (SHAs),
responsible for provision and funding health care services
in the UK.8 The service targets interventions by person,
place and time, requiring a method of stratifying COPD
patients by risk of exacerbation, and an understanding of
how that risk varies through the winter in different parts
of England.
COPD exacerbations occur at all stages of the disease but
become more common as lung function declines.9,10 An
exacerbation is defined as a sustained worsening of the
patient’s condition, from the stable state and beyond normal
day-to-day variations, that is acute in onset.11 Previous
studies suggest that some mild exacerbations are not
reported to clinicians and effectively self-managed by
patients at home. Some exacerbations are managed in the
community by general practitioners. However, it is the
exacerbations that result in admission to hospital that are
the most disruptive to patients and expensive to health care
systems. Between 16% and 22% of patients with exacerba-
tions are admitted to hospital,12 and it is these exacerba-
tions that are analysed in this study. The Health Resource
Group tariff for a severe exacerbation requiring hospital
admission without/with complications was £1726/£2367 in
2005/06.13 While the nature of COPD exacerbations may be
very heterogeneous, it is conceivable that a proportion of
those without complications may be managed in the
community by a general practitioner or outpatient clinic, or
even at home, costing £95 and £14 respectively.5,13,14
Previous studies have shown that that overall admission
rates can be predicted using a combination of epidemiolog-
ical and environmental data,15,16 and that patients admitted
to hospital often have risk factors that could be modi-
fied.17,18 Within the population of patients with COPD, some
appear to be at higher risk of requiring hospitalisation.
Different healthcare systems have tried various means of
identifying the most vulnerable patients. Two of the most
consistent predictors of hospitalisation are exacerbation
frequency and a history of a previous admission, particularly
within the last year.18,19,20 This approach has been used by
organisations such as Castlefields Health Centre and the
Evercare model of care management, to classify patients as
high risk if they have been admitted more than twice in the
previous 12 months.21,22 However, many other factors
contribute to the risk of an admission. The Department of
Health PARR (Patients at Risk of Re-hospitalisation) project
has developed a model using hospital patient details to
predict high-risk patients, and this will soon integrate
primary care data.23
The study was funded by the Met Office as part of
development of the pilot COPD Health Forecasting and
Anticipatory Care service.8 Building on previous studies,
this study postulated that COPD patients could be stratified
by risk of exacerbation requiring admission, to determine
the patient groups which provide the greatest burden on
resources, how risk varies during winter, and hence when
and how interventions should be targeted to reduce
admissions. It was anticipated that there would be impli-
cations for implementation of health policy aimed at
reducing bed days, and an application in development of
a protocol of interventions and anticipatory care as part of
the Met Office/NHS service.
Methods
Data
The design was a retrospective cohort population-based
study, using data from the Hospital Episode Statistics (HES)
database. HES is the national warehouse for England of
statistical data of the care provided by NHS hospitals and
for NHS hospital patients treated elsewhere. The HES
database is a record level database of hospital admissions.
Each patient has a unique anonymised identifier, which can
be traced between records.
Data for COPD emergency admissions (diagnosis of ICD10
J40-44) were extracted from the HES database for the
period April 1997eMarch 2003, for all NHS organisations in
Birmingham and the Black Country SHA; Cheshire & Mer-
seyside SHA; and Norfolk, Suffolk and Cambridgeshire SHA.
These SHAs were chosen as they were participants in the
pilot Met Office/NHS service, with different geographical
and socioeconomic characteristics. We aimed to establish
that our conclusions could be independent of population,
rather than to explain any geographical variation, which
was out of scope of this study. All COPD admissions between
1 April 1997 and 31 March 2003 were included in the study.
In-hospital mortality during the period of study was not
corrected for.
Data for COPD prevalence in the three SHAs were
available from the Quality Outcomes Framework (QOF) of
the new general medical services contract.24 Data
describing the SHA populations were available from QOF
and general practice registered population data.25 Data for
smoking were available from the Health Development
Agency report The smoking epidemic in England.26
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Analysis
The data were primarily analysed using pivot tables and
look-up tables in Microsoft Excel. Relationships between
variables were explored using linear regression. Winter was
defined as the period from 1 November to 31 March, chosen
as the months clinically associated with the highest number
of COPD admissions. Two measures of risk were calculated:
1. the risk of admission of patients, according to their
previous admissions;
2. the risk level of each week during winter, according to
the standard deviations of admissions above the long-
term mean.
Each patient appearing in the HES data was stratified
according to how many admissions they had had during
the 12 months prior to 1 November of each year. So at
the beginning of winter, there was a category of patients
who had been admitted once in the previous 12 months,
and other categories who had been admitted 2, 3, 4, or
5 times. The risk of admission was defined as the
proportion of patients in each category who were subse-
quently admitted during winter. Linear regression was
used to determine how much the variation in this risk
between categories could be explained by the number of
previous admissions. The total number of admissions and
average length of stay for each category were also
calculated. Again, linear regression was used to deter-
mine how much the variation in average length of stay
between categories could be explained by the number of
previous admissions.
The initial categorisation was then simplified to two
groups: 1e2 previous admissions (MOD group) or 3
previous admissions (FRQ group). A third group was defined,
comprising patients who were admitted during the winter,
but had not been admitted during the previous 12 months
(NIL group). These patients may have had an admission
more than 12 months ago, but otherwise it was not possible
using admissions data alone to estimate the size of this
group of patients at the beginning of winter. Instead, an
estimate of the risk of admission was calculated as the ratio
of total winter admissions of NIL patients, averaged over
the years 1997/98e2002/03, against QOF data for COPD
register counts in 2004/05.24
The risk level of each week was found by comparing
admissions during the week with the long-term mean. The
HES data were summed to give a daily time-series of
admissions. Linear regression was used to determine how
much of the variation in daily admissions could be
explained by a trend variable. Significant trends were
removed from the data. Detrended daily admissions were
summed to give weekly admissions, and the long-term
mean weekly admissions and standard deviations (SDs)
calculated. The risk level of each week during winter was
classified as ‘‘average’’, (less than 0.5 SDs above the long-
term mean) ‘‘above average’’ (between 0.5 and 1.5 SDs
above the mean), ‘‘high’’ (between 1.5 and 3.0 SDs above
the mean), and ‘‘very high’’ (more than 3.0 SDs above the
mean).
For each patient group (NIL, MOD and FRQ), the number
of admissions in each week and the average admissions by
risk level of week were calculated. For each patient group,
linear regression was used to determine how much the
week-by-week variation in average admissions could be
explained by the risk level of the week.
Results
There were substantial differences in the prevalence of
COPD, the annual admission rates for COPD per person aged
over 65 and the mean daily admissions for COPD between
the three SHAs (Table 1). Nevertheless there were similar
temporal trends in admission rates across the SHAs and
there was no statistically significant variation in length of
stay between winters, SHAs or groups of patients.
Table 1 Characterising COPD in three Strategic Health Authorities (SHAs).
Financial year Cheshire & Merseyside
SHA
Birmingham and the
Black Country SHA
Norfolk, Suffolk and
Cambridgeshire SHA
Total
Number of COPD admissions6
1997/98 5554 3278 2682
1998/99 6319 3730 3093
1999/00 6670 3867 3094
2000/01 6690 3846 2980
2001/02 6596 4049 3117
2002/03 6705 4876 3145
Total admissions 38534 23646 18111 80291
Mean daily admissions 17.6 10.8 8.3 36.6
Standard deviation 7.3 5.2 4.4 14.2
Number of COPD patients 20383 13354 10763 44486
Prevalence of COPD
Average age of admissions6 71.3 71.4 72.2
Population over 6525 393408 361721 403594
Admissions pa per pop. over 65 0.016 0.011 0.007
COPD prevalence24 2.0% 1.3% 1.3%
Smoking prevalence26 29% 29% 27%
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The profile of admissions for each SHA shows an upwards
trend and seasonal variation with a peak in winter with
varying amplitude year by year (illustrated for Cheshire &
Merseyside SHA in Figure 1).
On average across all SHAs and all winters between
1998/99 and 2002/03, 75% of patients admitted had had no
admissions (NIL group) during the previous 12 months.
Twenty per cent had had 1e2 previous admissions (MOD
group), and 5% had had 3 previous admissions (FRQ
group). Some of the patients were admitted more than
once. NIL patients who were admitted had an average of
1.1 admissions during the same winter (i.e. on average 0.1
re-admissions), MOD had 1.3 admissions and FRQ 2.0
admissions. NIL patients account for 70% of all winter
admissions, MOD 22% and FRQ 8%.
Previous admissions in the last 12 months (categorised as
1, 2, 3, 4, 5þ) were highly predictive of future admissions in
the following winter (R2 > 0.90, p < 0.001). Using the
simplified classification of NIL, MOD and FRQ, the risk of
admission during winter was 40% for FRQ patients and 12%
for MOD (Table 2). The QOF-based estimate of risk for NIL
patients (ratio admissions of these patients admitted during
winter to COPD register counts) gave a 4% risk of admission.
Sixty-five per cent of weeks during the winters of 1997/
98e2002/03 were classified as ‘‘average’’ risk, 21% as
‘‘above average’’, and 8% as ‘‘high’’ and 6% as ‘‘very high’’.
Typically, the higher weeks occur during the peaks of
influenza epidemics, and the highest when the influenza
peak coincides with a period of low temperatures. Outside
the winters, there are very few weeks that are not
‘‘average’’.
The numbers of admissions during winter, and the
breakdown by patient group, varies substantially with the
risk level of the week (Table 3). As the risk level of the
week increases, admissions and bed days increase
substantially, with NIL patients accounting for most of the
variation.
During ‘‘average’’ risk weeks in winter, NIL patients
made up 67% of admissions, compared with 24% MOD and
10% FRQ. During ‘‘very high’’ risk weeks, NIL patients made
up 81% of admissions, compared with 15% MOD and 4% FRQ.
Averaged over all winters and SHAs, weekly admissions
increased by 150% between ‘‘average’’ and ‘‘very high’’ risk
weeks; admissions of NIL patients increased by 204% (vari-
ation between weeks significant to p < 0.001) compared
with 51% (p < 0.001) and 14% (not significant) for MOD and
FRQ patients respectively. NIL patients made up 90% of the
variation between ‘‘average’’ and ‘‘very high’’ weeks,
compared with 9% and 1% for MOD and FRQ patients.
Length of stay was not found to vary significantly with
number of previous admissions in any of the SHAs, and
hence trends in numbers of admissions and in bed days are
similar when analysed according to the previous admission
category of the patients.
From these data we calculated that a reduction of 5% in
COPD emergency bed days during winter is equivalent to
either a reduction of 62% in bed days (or admissions) of FRQ
patients, or a 23% reduction in bed days (or admissions) of
MOD patients, or a 7% reduction in bed days (or admissions)
of NIL patients.
Discussion
Our results clearly confirm that COPD patients with
a previous history of admissions are more at individual risk
of readmission. However, at a population level COPD
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Figure 1 Daily admissions in Cheshire & Merseyside SHA.
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patients with no admissions in the previous 12 months are
responsible for the greatest winter hospitalisation burden
and most of the week-on-week variation in hospitalisations.
Patients with no previous admission account for two-thirds
of admissions during winter, and 90% of variation in
admissions and bed days between ‘‘average’’ and ‘‘very
high’’ risk level weeks. Our data suggest that patients with
no previous admissions for COPD should be targeted with
preventative care. This may result in more efficient
management of total winter admissions and peaks in
demand. However, in order to achieve this it is essential
that the huge problem of COPD underdiagnosis is
addressed. Unless strategies such as screening smokers with
respiratory symptoms using spirometry are introduced, the
first time some patients will be diagnosed will be at the
time of their admission with an exacerbation.
The outcomes of this study were used in the pilot Met
Office/NHS COPD Health Forecasting and Anticipatory Care
service, and the analysis was based on the service’s need
for a simple and pragmatic method of stratifying patients at
the beginning of each winter. The number of previous
admissions in the past year is a very good predictor of
future admissions and better than FEV1 (forced expiratory
volume in 1 second).27 For health care institutions wanting
to use Health Forecasting, admissions data are more likely
to be available than more complex models of prediction.
Stratifying by admissions in the previous 12 months, rather
than for 3 years or longer, minimises the time required to
search case notes for recorded admissions. Furthermore,
the HES database is only available back to 1997/98, which
both gives a limited dataset and truncates the patient
record. It would be useful to follow up this analysis using
methodologies such as Cox regression or time-series anal-
ysis, to confirm the findings.
A further potential limitation of the study is the reliance
on accurate coding of COPD in the HES data, which is not
necessarily consistent between organisations. However, the
biases in the coding are likely to be consistent across
organisations and the large number of Trusts contributing
data make it unlikely that these differences will have
a significant impact on our conclusions. The HES database is
the definitive record of all admissions in each of the SHAs,
and is therefore totally representative of these pop-
ulations. Furthermore, epidemiological patterns are
consistent across COPD data sources and healthcare use is
likely to reflect the underlying prevalence and severity of
disease.28 The data period of study predates the introduc-
tion of the new general practice contract, which
Table 2 Number of patients with admissions in 12 months preceding each winter, subsequent admission during winter and
length of stay categorised by number of previous admissions.
Cheshire & Merseyside SHA Birmingham and the Black Country
SHA
Norfolk, Suffolk and
Cambridgeshire SHA
0 (NIL) 1e2 (MOD) 3þ (FRQ) 0 (NIL) 1e2 (MOD) 3þ (FRQ) 0 (NIL) 1e2 (MOD) 3þ (FRQ)
Number of patients with admissions in 12 months preceding winter
1998/99 3779 320 2512 155 2133 131
1999/00 4560 367 2621 189 2197 121
2000/01 4524 403 2836 195 2429 141
2001/02 4347 406 2732 222 2129 165
2002/03 4488 425 3077 282 2201 168
Total 21698 1921 13778 1043 11089 726
Number of patients admitted during winter
1998/99 2166 508 130 1296 283 67 1131 218 43
1999/00 2075 586 149 1469 284 82 1242 235 46
2000/01 1823 614 169 1207 328 80 918 244 53
2001/02 1875 555 158 1258 341 92 977 239 54
2002/03 1729 575 174 1311 370 117 892 241 67
Total 9668 2838 780 6541 1606 438 5160 1177 263
Risk of admission during winter
1998/99 13% 41% 11% 43% 10% 33%
1999/00 13% 41% 11% 43% 11% 38%
2000/01 14% 42% 12% 41% 10% 38%
2001/02 13% 39% 12% 41% 11% 33%
2002/03 13% 41% 12% 41% 11% 40%
Total 13% 41% 12% 42% 11% 36%
Average length of stay during winter (days)
1998/99 10.29 10.22 10.69 9.27 12.08 8.50 9.51 9.23 9.39
1999/00 10.19 10.79 10.37 9.73 9.94 12.63 9.24 10.44 12.62
2000/01 10.91 11.65 10.08 10.84 9.71 12.47 10.37 10.61 8.61
2001/02 11.26 11.75 12.21 11.24 12.54 11.15 9.78 11.20 10.39
2002/03 9.50 9.64 11.05 8.38 9.95 9.72 9.19 8.88 10.50
Total 10.44 10.82 10.88 9.86 10.82 10.77 9.59 10.08 10.35
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encouraged more rigorous assessment and diagnosis of
patients with COPD in primary care. A clinical audit of
primary and secondary care pathways could usefully expose
any variations in coding, as well as highlight how many
patients admitted with COPD have not been previously
diagnosed.
The NIL group makes up the majority of COPD admis-
sions, and can include patients diagnosed with COPD during
the admission but with no previous diagnosis. Research is
required to identify if there is a sub-group of COPD patients
in the NIL group who are most at risk of admission or
exacerbation. One way to address this is to use a multi-
dimensional assessment tool such as the Clinical COPD
Questionnaire (CCQ) to identify the patients with no
previous admissions who have a higher risk of future
admission.29,30 Year round, the weeks that are classified as
‘‘above average’’, ‘‘high’’ or ‘‘very high’’ account for 16%
of all weeks but 24% of all admissions. These are the weeks
when low-risk patients have a higher risk of admission. We
are not in a position to address the reasons behind the
differences in variation in admission rates between the NIL,
MOD and FRQ groups. The data suggest that hospitalisation
in MOD and FRQ patients is less dependent on variable
factors such as infections and climate and may be more
influenced by small variations in underlying disease severity
and co-morbidities. The important point is that the
majority of admissions and variation in admissions are seen
in the NIL group and therefore these patients are the ones
who must be considered when trying to reduce admissions.
Although there were substantial differences in the preva-
lence of COPD and annual admission rates across the three
SHAs, similar temporal trends were observed. The preva-
lence of COPD shows geographical variation24 but we found
that there was no statistically significant variation in length
of stay between groups of patients, winters or SHAs. Thus,
it seems unlikely that regional differences have had any
significant impact on the detailed results, and further
exploration of geographical factors was not undertaken.
The Department of Health in England has outlined an
objective and associated performance target to ‘‘improve
health outcomes for people with long-term conditions by
offering a personalised care plan for vulnerable people
most at risk; and to reduce emergency bed days by 5% by
2008, through improved care in primary care and
community settings for people with long-term condi-
tions.’’7 COPD is a long-term condition and our data show
that patients with three or more admissions during the last
12 months (FRQ group) are the ‘‘vulnerable people most at
risk’’. In keeping with previous findings,19e23 we have
confirmed that for COPD patients the number of previous
admissions is highly predictive of future admissions. The
FRQ group shows the least variation in admissions/bed
days throughout the year, suggesting that if case
management works it may reduce the risk of future
admissions in this easily-identifiable group. However, these
patients account for only about 8% of total winter bed
days. To reduce emergency bed days during winter by 5%
one would have to prevent 62% of these high-risk patients
from being admitted, which is a considerable challenge,
especially as many of these admissions are likely to be
appropriate. Because there was no significant difference in
length of stay between NIL and FRQ patients, reducing
admissions among frequently-admitted patients would not
bring any multiplicative saving in terms of bed days.
Alternatively, just a 7% reduction in COPD admissions in
the NIL group would achieve the 5% reduction in emer-
gency bed days. This is also a challenge since the risk of
admission for each patient is much lower, and there are
Table 3 Average admissions per week and length of stay in winter categorised by number of previous admissions and risk level
of week.
Cheshire & Merseyside
SHA
Birmingham and the
Black Country SHA
Norfolk, Suffolk and
Cambridgeshire SHA
0
(NIL)
1e2
(MOD)
3þ
(FRQ)
0
(NIL)
1e2
(MOD)
3þ
(FRQ)
0
(NIL)
1e2
(MOD)
3þ
(FRQ)
Average admissions per week in winter
Average 82.49 32.96 13.97 56.39 18.34 7.92 42.42 13.35 4.03
Above average 115.33 39.67 15.67 73.12 20.40 7.84 61.78 18.28 5.39
High 147.57 43.71 14.29 99.00 25.78 11.11 82.67 16.33 6.11
Very high 261.80 56.80 15.60 144.86 24.86 9.29 142.83 19.33 4.50
All weeks 102.88 36.34 14.46 69.92 19.90 8.27 54.92 14.79 4.47
Significance of
variation with
risk level of week
p < 0.001 p < 0.001 not sig p < 0.001 p < 0.05 not sig p < 0.001 p < 0.05 not sig
Average length of stay in winter
Average 10.34 10.80 10.62 9.89 10.42 10.78 9.84 9.99 10.97
Above average 10.91 11.12 11.36 10.29 10.98 11.44 9.70 9.84 8.10
High 10.57 10.76 11.33 9.85 12.64 8.69 9.12 10.30 11.16
Very high 9.77 10.06 11.23 9.03 10.66 11.89 8.96 11.30 10.00
All weeks 10.44 10.82 10.88 9.86 10.82 10.77 9.59 10.08 10.35
Significance of
variation with
risk level of week
not sig not sig not sig not sig not sig not sig not sig not sig not sig
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many more of these patients with mild symptoms and
some with no current COPD diagnosis.31
Any intervention that seeks to reach the low-risk
patients needs to address the fact that they constitute the
vast majority on the COPD register. The Met Office/NHS
COPD Health Forecasting and Anticipatory Care service
aims to target the right preventative care to the right
cohort of patients at the right time. During the winters of
2004/05 and 2005/06, the Met Office provided the service
to more than 40 Primary Care Trusts in England. Partici-
pating general practices stratified their registers into NIL,
MOD, FRQ groups. All patients were provided with an
education pack at the beginning of the winter, containing
basic information about COPD and Health Forecasting,
evidenced-based actions that they can take to protect
themselves, and two thermometers to ensure they are
keeping their house warm enough. The Met Office provided
forecasts twice-weekly of the risk of exacerbation for the
next week. Practices then contacted patients with antici-
patory care according to the protocol: FRQ patients were
contacted when the forecast was ‘‘above average’’ or
higher, MOD patients when the forecast was ‘‘high’’ or
higher, and NIL patients when the forecast was ‘‘very
high’’. Hence the high-risk but small group were contacted
more frequently, and the low-risk but large group less
frequently when the forecast risk was higher. Health
Forecasting does not extend case management to the
lower-risk patients, but complements it through empow-
ering patients for self-care through education and timely
reminders. Patient contact and anticipatory care by the
practice was according to national guidelines,11 and aimed
at reducing risk. Care included for example support for
smoking cessation, ensuring COPD patients were aware of
their symptoms, and had adequate medication at home and
knew who to call for advice in the case their symptoms
worsened. Preliminary evidence from the 2005/06 pilot
showed reductions in the admissions of 25e75% across
practices which took part in different SHAs. Practices in the
regions which did not participate saw either substantially
smaller reductions or increases. This is borne out by find-
ings from the East London Study that patient recognition of
exacerbation symptoms and prompt treatment improves
exacerbation recovery, reduces risks of hospitalisation, and
is associated with a better health-related quality of life.32
The service was further developed in the winter of 2006/
07, when the Met Office is trialled an automated patient
contact system aimed at further reducing the burden on
practices of contacting the low-risk patients. Again, all
patients are provided with the education pack. When the
Health Forecast indicates a period of increased risk, this
system automatically telephones the patient at a time they
have indicated is convenient. An interactive script asks
questions about the patient’s symptoms and whether they
have enough medication at home in case their symptoms
worsen. The patient’s responses are logged, and the prac-
tice is alerted to follow up those patients who have indi-
cated worse symptoms and/or no medication.
In conclusion, most patientsadmitted during winter in
this study had had no admission for COPD during the
previous year. These patients accounted for over 90% of
variation in admissions between ‘‘average’’ and ‘‘very
high’’ weeks. Patients with no previous admissions have
lower individual risk, but contribute considerably to a high
overall utilisation of health care resources and should be
targeted to prevent admissions. Focusing upon high-risk
patients (frequent attenders or more severe) may only
reduce a small proportion of admissions, and therefore
clinicians should ensure that all COPD patients receive
appropriate therapy to reduce risk of exacerbations.
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